These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10870734)

  • 21. Neurotrophic factors: important regulators of nociceptive function.
    Bennett DL
    Neuroscientist; 2001 Feb; 7(1):13-7. PubMed ID: 11486340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nerve growth factor induces P2X(3) expression in sensory neurons.
    Ramer MS; Bradbury EJ; McMahon SB
    J Neurochem; 2001 May; 77(3):864-75. PubMed ID: 11331415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in neuropharmacology of cutaneous nociceptors.
    Nakamura A; Shiomi H
    Jpn J Pharmacol; 1999 Apr; 79(4):427-31. PubMed ID: 10361881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glial cell line-derived neurotrophic factor increases calcitonin gene-related peptide immunoreactivity in sensory and motoneurons in vivo.
    Ramer MS; Bradbury EJ; Michael GJ; Lever IJ; McMahon SB
    Eur J Neurosci; 2003 Nov; 18(10):2713-21. PubMed ID: 14656320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression changes of glial cell line-derived neurotrophic factor in a rat model of neuropathic pain.
    Takahashi N; Nagano M; Suzuki H; Umino M
    J Med Dent Sci; 2003 Mar; 50(1):87-92. PubMed ID: 12715924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nerve growth factor and chronic daily headache: a potential implication for therapy.
    Sarchielli P; Gallai V
    Expert Rev Neurother; 2004 Jan; 4(1):115-27. PubMed ID: 15853622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of integrin β1/FAK signaling in the analgesic effects induced by glial cell line-derived neurotrophic factor in neuropathic pain.
    Wang HJ; Song G; Liang J; Gao YY; Wang CJ
    Brain Res Bull; 2017 Oct; 135():149-156. PubMed ID: 29031858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demyelination/remyelination and expression of interleukin-1β, substance P, nerve growth factor, and glial-derived neurotrophic factor during trigeminal neuropathic pain in rats.
    Costa GMF; de Oliveira AP; Martinelli PM; da Silva Camargos ER; Arantes RME; de Almeida-Leite CM
    Neurosci Lett; 2016 Jan; 612():210-218. PubMed ID: 26687274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotrophins in the cerebrospinal fluid of patient cohorts with neuropathic pain, nociceptive pain, or normal pressure hydrocephalus.
    Capelle HH; Weigel R; Schmelz M; Krauss JK
    Clin J Pain; 2009 Oct; 25(8):729-33. PubMed ID: 19920725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The progressive tactile hyperalgesia induced by peripheral inflammation is nerve growth factor dependent.
    Ma QP; Woolf CJ
    Neuroreport; 1997 Mar; 8(4):807-10. PubMed ID: 9141043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glial cell line-derived neurotrophic factor normalizes neurochemical changes in injured dorsal root ganglion neurons and prevents the expression of experimental neuropathic pain.
    Wang R; Guo W; Ossipov MH; Vanderah TW; Porreca F; Lai J
    Neuroscience; 2003; 121(3):815-24. PubMed ID: 14568039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance.
    Wild KD; Bian D; Zhu D; Davis J; Bannon AW; Zhang TJ; Louis JC
    J Pharmacol Exp Ther; 2007 Jul; 322(1):282-7. PubMed ID: 17431136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain-derived neurotrophic factor redistribution in the dorsal root ganglia correlates with neuropathic pain inhibition after resiniferatoxin treatment.
    Tender GC; Li YY; Cui JG
    Spine J; 2010 Aug; 10(8):715-20. PubMed ID: 20452292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraventricular infusion of nerve growth factor as the cause of sympathetic fiber sprouting in sensory ganglia.
    Nauta HJ; Wehman JC; Koliatsos VE; Terrell MA; Chung K
    J Neurosurg; 1999 Sep; 91(3):447-53. PubMed ID: 10470820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of neurotrophic factors in genesis and maintenance of mechanical hypernociception after brachial plexus avulsion in mice.
    Quintão NL; Santos AR; Campos MM; Calixto JB
    Pain; 2008 May; 136(1-2):125-33. PubMed ID: 17706869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mechanism-based understanding of bone cancer pain.
    Mantyh PW
    Novartis Found Symp; 2004; 261():194-214; discussion 214-9, 256-61. PubMed ID: 15469052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoid 1 receptors are expressed by nerve growth factor- and glial cell-derived neurotrophic factor-responsive primary sensory neurones.
    Ahluwalia J; Urban L; Bevan S; Capogna M; Nagy I
    Neuroscience; 2002; 110(4):747-53. PubMed ID: 11934481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biological actions of nerve growth factor in pain sensation].
    Wei F; Zhang J
    Sheng Li Ke Xue Jin Zhan; 1997 Apr; 28(2):172-4. PubMed ID: 11038719
    [No Abstract]   [Full Text] [Related]  

  • 39. Nociceptor hyper-responsiveness during vincristine-induced painful peripheral neuropathy in the rat.
    Tanner KD; Reichling DB; Levine JD
    J Neurosci; 1998 Aug; 18(16):6480-91. PubMed ID: 9698336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291.
    McArthur JC; Yiannoutsos C; Simpson DM; Adornato BT; Singer EJ; Hollander H; Marra C; Rubin M; Cohen BA; Tucker T; Navia BA; Schifitto G; Katzenstein D; Rask C; Zaborski L; Smith ME; Shriver S; Millar L; Clifford DB; Karalnik IJ
    Neurology; 2000 Mar; 54(5):1080-8. PubMed ID: 10720278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.